UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in HALO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,901,059
-$6,225,581 QoQ
Shares Held
356,472
-32.5% QoQ
Ownership
0.314%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#66
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. HALO ranks #26 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in HALO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,901,059 | 356,472 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $34,126,640 | 528,031 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $49,368,718 | 733,562 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $23,979,754 | 326,967 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,819,809 | 496,344 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,561,674 | 416,262 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $18,639,919 | 389,875 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,771,957 | 397,833 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,620,770 | 432,024 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $6,547,607 | 160,954 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,957,210 | 161,180 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,017,911 | 157,537 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,069,307 | 334,608 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,778,677 | 334,608 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $29,501,453 | 518,479 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $20,558,860 | 519,951 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,782,016 | 176,864 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,678,501 | 167,465 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,066,399 | 150,868 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,009,980 | 147,738 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,051,943 | 155,295 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,299,441 | 151,102 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,584,897 | 154,177 | Shares | Sole | 2021-03-01 | |
| 2020-09-30 | $3,710,733 | 141,200 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,897,957 | 145,392 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $15,708,722 | 873,192 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||